A
AustralianSuper Portfolio holdings
AUM
$19.8B
This Quarter Return
+14.08%
1 Year Return
+24.18%
3 Year Return
+90.64%
5 Year Return
+141.87%
10 Year Return
–
AUM
$16.7B
AUM Growth
+$16.7B
(+7.9%)
Cap. Flow
-$781M
Cap. Flow
% of AUM
-4.69%
Top 10 Holdings %
Top 10 Hldgs %
38.53%
Holding
262
New
27
Increased
100
Reduced
70
Closed
21
Top Buys
| 1 |
Edwards Lifesciences
EW
|
$169M |
| 2 |
KLA
KLAC
|
$143M |
| 3 |
AbbVie
ABBV
|
$127M |
| 4 |
Bristol-Myers Squibb
BMY
|
$87M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$79.9M |
Top Sells
| 1 |
Apple
AAPL
|
$249M |
| 2 |
Intel
INTC
|
$174M |
| 3 |
Microsoft
MSFT
|
$142M |
| 4 |
Alphabet (Google) Class C
GOOG
|
$141M |
| 5 |
Danaher
DHR
|
$135M |
Sector Composition
| 1 | Technology | 19.27% |
| 2 | Consumer Discretionary | 18.6% |
| 3 | Financials | 17.94% |
| 4 | Healthcare | 13.6% |
| 5 | Communication Services | 10.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Northrop Grumman
NOC
$83.2B
| $174M | 1.04% |
371,314
-22,657
| -6% | -$10.6M |
|
|
27
Edwards Lifesciences
EW
$47.7B
| $169M | 1.01% |
+2,210,083
| New | +$169M |
|
28
HEICO Class A
HEI.A
$34.9B
| $167M | 1% |
1,173,364
+323,371
| +38% | +$46.1M |
|
29
Nike
NKE
$110B
| $151M | 0.9% |
1,387,830
+345,991
| +33% | +$37.6M |
|
30
Icon
ICLR
$14B
| $148M | 0.89% |
522,828
| – | – |
|
|
31
KLA
KLAC
$111B
| $145M | 0.87% |
250,147
+246,244
| +6,309% | +$143M |
|
32
MSCI
MSCI
$42.7B
| $144M | 0.86% |
253,990
+39,738
| +19% | +$22.5M |
|
33
Capital One
COF
$142B
| $134M | 0.81% |
1,023,204
+137,209
| +15% | +$18M |
|
34
AT&T
T
$208B
| $133M | 0.8% |
7,899,845
+1,516,142
| +24% | +$25.4M |
|
|
DFS
35
DELISTED
Discover Financial Services
DFS
| $132M | 0.79% |
1,176,384
+319,697
| +37% | +$35.9M |
|
36
Stellantis
STLA
$26.4B
| $132M | 0.79% |
5,657,057
-61,596
| -1% | -$1.44M |
|
|
37
AbbVie
ABBV
$374B
| $128M | 0.77% |
828,661
+819,251
| +8,706% | +$127M |
|
38
Manulife Financial
MFC
$51.7B
| $128M | 0.77% |
5,793,161
+582,468
| +11% | +$12.9M |
|
39
Synchrony
SYF
$28.1B
| $125M | 0.75% |
3,282,015
+371,304
| +13% | +$14.2M |
|
40
Valero Energy
VLO
$48.3B
| $122M | 0.73% |
938,771
+250,326
| +36% | +$32.5M |
|
41
MetLife
MET
$53.6B
| $121M | 0.72% |
1,824,596
+293,925
| +19% | +$19.4M |
|
42
State Street
STT
$32.1B
| $118M | 0.71% |
1,529,109
+203,692
| +15% | +$15.8M |
|
43
Viatris
VTRS
$12.3B
| $117M | 0.7% |
10,793,538
+3,261,384
| +43% | +$35.3M |
|
44
HP
HPQ
$26.8B
| $116M | 0.69% |
3,843,822
+656,888
| +21% | +$19.8M |
|
45
Marathon Petroleum
MPC
$54.4B
| $115M | 0.69% |
776,282
+222,157
| +40% | +$33M |
|
46
West Pharmaceutical
WST
$17.9B
| $113M | 0.68% |
322,288
| – | – |
|
47
Nucor
NUE
$33.3B
| $108M | 0.65% |
622,277
+56,400
| +10% | +$9.82M |
|
48
Accenture
ACN
$158B
| $104M | 0.63% |
296,850
-111,455
| -27% | -$39.1M |
|
49
Dell
DELL
$83.9B
| $102M | 0.62% |
1,339,514
+164,930
| +14% | +$12.6M |
|
50
Teva Pharmaceuticals
TEVA
$21.5B
| $94.4M | 0.57% |
9,039,070
+1,431,671
| +19% | +$14.9M |
|